Probe Silencing With Blocker Oligonucleotides for Spatial Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing spatial analysis methods fail to provide information on the position of single cells within a tissue sample and indiscriminately detect analytes, including those not of interest, leading to poor performance and reduced efficiency in determining analyte location and abundance.

Innovation Solution

The method involves designing synthetic antisense molecules to selectively silence probes used in templated ligation processes, using blocker oligonucleotides to block hybridization with undesired analytes, thereby improving the efficiency of spatial analysis by selectively reducing or excluding overexpressed analytes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If capture probes are used to detect analytes in spatial analysis, then analyte detection is achieved, but off-target analytes are also detected indiscriminately leading to poor performance

Engineering Contradiction:
Improveanalyte detection specificityVSAvoidoff-target analyte detection
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by introducing blocker oligonucleotides that are complementary to probes targeting highly expressed genes (such as SERF1A) before the templated ligation process. These blockers hybridize to the probes in advance, preventing them from binding to their target analytes during the detection process. This pre-blocking strategy selectively silences probes that would otherwise cause off-target detection and sequencing saturation, thereby improving measurement precision without sacrificing overall detection capability

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The blocker oligonucleotides serve as intermediaries between the probe set and the highly expressed analytes. Rather than directly removing the problematic probes or analytes, the blockers mediate the interaction by binding to probes and preventing their engagement with target analytes. This intermediary approach allows selective silencing of specific probes while maintaining the integrity of the overall templated ligation system and preserving spatial information

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If templated ligation probes are used to achieve coverage of entire transcriptome, then comprehensive analyte detection is achieved, but highly expressed analytes cause sequencing saturation and reduce efficiency

Engineering Contradiction:
Improvetranscriptome coverageVSAvoidspatial analysis efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent applies partial action by selectively silencing only the subset of probes that target highly expressed genes, rather than removing all probes or reducing overall detection sensitivity. The blocker oligonucleotides are designed to specifically target probes for genes like SERF1A that are known to be highly expressed, allowing the majority of the transcriptome to remain detectable while preventing sequencing saturation from a small subset of overrepresented transcripts

Inventive Principle:
Principle #16Partial or excessive action

Solution Approach 2:

The invention changes the parameters of the detection system by introducing blocker oligonucleotides that alter the effective concentration and binding affinity of specific probes. By adjusting the blocker concentration and sequence specificity, the system dynamically controls which probes are silenced, enabling optimization of transcriptome coverage while preventing sequencing saturation from highly expressed analytes

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If probes targeting highly expressed genes are used, then detection sensitivity for those genes is improved, but sequencing saturation increases by 50% or more

Engineering Contradiction:
Improvegene detection sensitivityVSAvoidsequencing saturation level
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The blocker oligonucleotides are introduced in advance to hybridize with probes targeting highly expressed genes, preventing these probes from binding to their abundant targets during the templated ligation process. This preliminary blocking action maintains the ability to detect these genes at their native expression levels without allowing them to dominate the sequencing output, thereby reducing sequencing saturation while preserving detection sensitivity

Inventive Principle:
Principle #9Preliminary anti-action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the number of genes detected, sensitivity, and spatial diversity by 5-100% and reduces sequencing saturation levels by 50% or more, compared to methods without blocker oligonucleotides, thereby improving the accuracy and efficiency of spatial transcriptomic analysis.

Implementation Method 1

hybridizing the first blocker oligonucleotide to the first probe or the second probe, thereby blocking the first probe or the second probe from hybridizing to the first analyte or the second analyte

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentEP4726055A2Methods for spatial analysis using targeted probe silencing
Publication Date: 2026.04.15 10X GENOMICS INC
  • EP4726055A2 patent drawingFigure 1
  • EP4726055A2 patent drawingFigure 2
  • EP4726055A2 patent drawingFigure 3

AI summary

Provided herein are methods for selective silencing of one or more probes used in templated ligation, or RNA-templated ligation. In some embodiments, the selective silencing is achieved using one or more blocker oligonucleotides.